newsfilter
← Latest News
GlobeNewswire·

Mindset Pharma Recaps 2021 Milestones and Highlights

Evolving Pipeline of Psychedelic Compounds Focused on Improved Efficacy and Safety Advancing MSP-1014 as First Lead Drug Clinical Candidate to IND-Enabling Studies TORONTO, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE:MSET)